Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Bristol-Myers Squibb
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
For more information regarding BMS clinical trial participation, please visit www.BMSStudyConnect.com
Disease progression experienced during or after one prior platinum containing doublet chemotherapy
Stage IIIb/IV or recurrent disease
Male and Female ≥ 18 years of age
Measurable disease per RECIST 1.1
Performance Status ≤ 1
You may not be if
History of Carcinomatous meningitis
Active Central nervous system (CNS) metastases
History of auto immune diseases
Prior treatment with Docetaxel
Prior treatment with ipilimumab or any drug targeting T-Cell costimulation or checkpoint pathways
Clareo Health | Efficacy Study of Nivolumab Compared to Docetaxel in Subjects Previously Treated With Advanced or Metastatic Non Small Cell Lung Cancer
